SRGN mRNA (Figure 1a) and protein (Figure 1b) expression levels were significantly higher in the TNBC cells (MDA-MB-231 and BT549 cell), than other subtypes of BC cells (MCF7, T47D, BT474 and SKBR3 cells) (P<0.05, P<0.01 vs MCF cells). This evidence concerns the gene SRGN and breast cancer.